Biorepository

ISBER Launches New Best Practices: Recommendations for Repositories, Fifth Edition

Retrieved on: 
Monday, December 4, 2023

VANCOUVER, BC, Dec. 4, 2023 /PRNewswire-PRWeb/ -- The International Society for Biological and Environmental Repositories (ISBER) announces the release of the ISBER Best Practices: Recommendations for Repositories, Fifth Edition. This is the definitive best practices guide for biological and environmental repositories across the world. (Available for download at www.isber.org/bpr).

Key Points: 
  • ISBER Launches New Best Practices Recommendations for Repositories, Fifth Edition at https://www.isber.org/page/bpr
    VANCOUVER, BC, Dec. 4, 2023 /PRNewswire-PRWeb/ -- The International Society for Biological and Environmental Repositories (ISBER) announces the release of the ISBER Best Practices: Recommendations for Repositories, Fifth Edition.
  • ISBER Best Practices: Recommendations for Repositories is a guidance document that reflects the collective experience of ISBER members and other repository professionals.
  • ISBER Launches New Best Practices Recommendations for Repositories, Fifth Edition at https://www.isber.org/page/bpr .
  • "The Fifth Edition of ISBER Best Practices stands as a testament to the altruistic spirit that fuels progress in our community" – Emma Snapes, Editor-in-Chief of the ISBER Best Practices Fifth Edition.

ATCC Appoints Dr. Alfredo Molinolo to Its Board of Directors

Retrieved on: 
Thursday, November 2, 2023

“Alfredo’s scientific expertise in pathology, oncology and histotechnology will be a great resource for our company,” said ATCC Chairman and CEO Raymond H. Cypess , DVM, PhD.

Key Points: 
  • “Alfredo’s scientific expertise in pathology, oncology and histotechnology will be a great resource for our company,” said ATCC Chairman and CEO Raymond H. Cypess , DVM, PhD.
  • Dr. Molinolo earned both his PhD in oncology and MD in medicine from the University of Buenos Aires in Argentina.
  • Dr. Molinolo has received several awards and has written numerous publications about breast, oral, and head and neck cancer.
  • “Serving on the Board is an opportunity for me to make further contributions to science,” said Dr. Molinolo.

Global Clinical Trial Biorepository and Archiving Solutions Market Report 2023-2031: The Impact of Blockchain on Clinical Trial Biorepositories and Ensuring Data Integrity Explored - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 7, 2023

The "Global Clinical Trial Biorepository and Archiving Solutions Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Clinical Trial Biorepository and Archiving Solutions Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.
  • The global clinical trial biorepository and archiving solutions market was valued at USD 3.91 billion in 2022, driven by the increasing complexity of clinical trials across the globe.
  • Clinical trial biorepository and archiving solutions play a crucial role in the storage, management, and preservation of biological samples and associated data collected during clinical trials.
  • This market introduction provides an overview of the clinical trial biorepository and archiving solutions market and highlights key trends shaping its growth.

Global Clinical Trial Biorepository and Archiving Solutions Market Report 2023-2031: Cloud-Based Storage Solutions, Automation, Blockchain and Robotics to Revolutionize the Industry

Retrieved on: 
Wednesday, August 30, 2023

DUBLIN, Aug. 30, 2023 /PRNewswire/ -- The "Global Clinical Trial Biorepository and Archiving Solutions Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 30, 2023 /PRNewswire/ -- The "Global Clinical Trial Biorepository and Archiving Solutions Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.
  • The global clinical trial biorepository and archiving solutions market was valued at USD 3.91 billion in 2022, driven by the increasing complexity of clinical trials across the globe.
  • Clinical trial biorepository and archiving solutions play a crucial role in the storage, management, and preservation of biological samples and associated data collected during clinical trials.
  • This market introduction provides an overview of the clinical trial biorepository and archiving solutions market and highlights key trends shaping its growth.

COFERTILITY SELECTS TMRW LIFE SCIENCES AS THEIR PREFERRED PARTNER FOR THE SAFE MANAGEMENT & STORAGE OF FROZEN EGGS & EMBRYOS

Retrieved on: 
Thursday, July 13, 2023

LOS ANGELES, July 13, 2023 /PRNewswire/ -- Cofertility, the human-centered fertility ecosystem offering a scalable approach to egg freezing and third-party reproduction, announced today their preferred partnership with TMRW Life Sciences (TMRW), a fertility technology company revolutionizing how frozen eggs and embryos are managed and stored. This partnership allows Cofertility members to access preferred egg or embryo storage rates at TMRW's BioRepository, the world's most innovative offsite cryostorage facility. Cofertility and TMRW are increasing access and raising the standard of care for fertility patients. 

Key Points: 
  • This partnership allows Cofertility members to access preferred egg or embryo storage rates at TMRW's BioRepository, the world's most innovative offsite cryostorage facility.
  • Cofertility and TMRW are increasing access and raising the standard of care for fertility patients.
  • "We're proud to partner with a company like TMRW that is similarly anchored by accessibility, transparency and autonomy," said Lauren Makler, CEO and Cofounder of Cofertility.
  • TMRW's ground-breaking automated technology platform digitally identifies, tracks, monitors and stores patients' frozen eggs and embryos with safety, accuracy, efficiency and transparency.

QuartzBio, a Part of Precision for Medicine, Acquires SolveBio and Expands Software-as-a-Service (SaaS) Data Management Solutions for Clinical Research & Development (R&D)

Retrieved on: 
Tuesday, January 24, 2023

FREDERICK, Md., Jan. 24, 2023 /PRNewswire/ -- Precision for Medicine, the first global, precision medicine clinical research services organization, today announced the strategic acquisition of SolveBio by QuartzBio.

Key Points: 
  • FREDERICK, Md., Jan. 24, 2023 /PRNewswire/ -- Precision for Medicine, the first global, precision medicine clinical research services organization, today announced the strategic acquisition of SolveBio by QuartzBio.
  • SolveBio's intelligent technologies and enterprise data management platform has integrated into QuartzBio's suite of SaaS solutions, providing a single, scalable solution supporting clinical sample inventory management and biomarker data management for the biotech and pharmaceutical sectors.
  • The combined offerings under QuartzBio provide scientific and operations teams in drug development with an agile, user-friendly data management platform that enables enterprise-level visibility across the lifecycle of their sample and biomarker data.
  • Leveraging this expanded enterprise suite of solutions, scientists in translational research and clinical operations can more easily collaborate across functions, analyze and report on key datasets, and generate insights.

Altasciences Receives Accreditation From College of American Pathologists

Retrieved on: 
Monday, October 31, 2022

The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Altasciences clinical site in Los Angeles, California, based on results of a recent on-site inspection.

Key Points: 
  • The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Altasciences clinical site in Los Angeles, California, based on results of a recent on-site inspection.
  • This prestigious accreditation is a testament to the high-quality work and oversight by Altasciences dedicated and passionate team in Los Angeles.
  • The CAP, first in the industry to offer an accreditation program for biorepositories, based the Biorepository Accreditation Program on the principles of its Laboratory Accreditation Program.
  • As the worlds largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing program, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide.

Bento Biology & Play2Learn Partner To Gamify Health Education For Children & Families In A Fun New Way In The MetaHug Roblox World

Retrieved on: 
Thursday, October 20, 2022

AUSTIN, Texas, Oct. 20, 2022 /PRNewswire/ -- Bento Biology, in partnership with Play2Learn, launches an exciting and immersive health-based experience on Roblox, the most popular metaverse platform with 58 million daily active users. The partnership will see games created around precision medicine, healthy biohacking, and tokenization of personal data for people to share, learn and earn from their biological data.

Key Points: 
  • Bento Biology and Play2Learn partnership will educate young people and families, allowing them to build and own avatars that represent their biology by leveraging the MetaHug Roblox virtual learning experience.
  • Bento DISCO (Decentralized Interactions for Shared-value Community 'Omics), Bento Biology's governance protocol, allows individuals to participate in the biotech economy as data owners, not data donors.
  • Their DISCO DAO strives to build a diverse community-owned biorepository to accelerate precision medicine and enable shared-value economic principles.
  • Bento Biology and Play2Learn will announce further details by November as they intend to explore new approaches and opportunities to engage Roblox users.

Slope Expands Go-To-Market Team for its eClinical Supply Chain Management Platform with Two Industry Veterans

Retrieved on: 
Wednesday, October 19, 2022

SAN FRANCISCO, Oct. 19, 2022 /PRNewswire/ -- Slope, provider of the first eClinical Supply Chain Management (eCSCM) platform, announced hiring two leaders with deep clinical trial expertise: Ben Carmel as Chief Revenue Officer and Matt Smith as Research Site Development Vice President. In his new role, Ben will engage with clinical trial sponsors and contract research organizations (CROs) to reduce clinical trial risks, rein in costs, improve the productivity of clinical trial collaborators, and increase subject enrollment and retention by moving the manual and error-prone processes used to manage and track clinical supplies and biological samples to a digital platform. Matt will engage with top academic research centers (AMCs) and clinical research sites to raise awareness and adoption of the Slope eCSCM platform. AMCs and clinical research sites use a free version of Slope to manage their clinical supply inventory—lab kits, investigational products (IP), devices, ancillary clinical supplies, and biological samples—so they are prepared for every subject procedure and never lose a sample.

Key Points: 

Slope Listed as a Sample Vendor in Gartner® Hype Cycle™ for Life Science Clinical Development, 2022 for Clinical Trial Resource Management

Retrieved on: 
Thursday, September 22, 2022

SAN FRANCISCO, Sept. 22, 2022 /PRNewswire/ -- Slope, provider of the first eClinical Supply Chain Management (eCSCM) platform, announced that it has been identified as a Sample Vendor in the 2022 Gartner Hype Cycle for Life Science Clinical Development, 2022. Slope was named in the Clinical Trial Resource Management category.[1]  Slope provides an online eClinical Supply Chain Management (eCSCM) platform for sponsors and research sites collaborating on complex, sample-intensive, and early-phase clinical trials in areas such as oncology, gene therapy, and rare disease.

Key Points: